Hims & Hers up 18% amid optimism for compounders with Makary FDA pick

by
Contributor since / Followers

15 hours ago

Hims & Hers Health (NYSE:HIMS) is up 18% Monday as the Street appears to believe that President-Elect Donald Trump’s nomination of Marty Makary for U.S. FDA Commissioner will be positive for drug compounders and companies that sell their products.
Besides

Tags: LLY